Drug Stocks Offer Long-Term Investment Opportunities
In a recent article I wrote that U.S. public healthcare spending is projected to exceed private spending by 2012. U.S. healthcare expenditures was estimated to reach about 17.3% of the GDP in 2009. One of the beneficiaries of all this spending are the companies in the healthcare industry such drug makers, health insurers, etc. They …
Continue reading ‘Drug Stocks Offer Long-Term Investment Opportunities’ »